Table 3 Summary of survival outcomes after diagnosis of brain metastases [32, 33, 37]
Primary Site | Median survival (months) | Surgery alone (months) | WBRT (months) | Surgery + WBRT (months) | Multimodal Surgery + RT +/− Chemo (months) |
|---|---|---|---|---|---|
Ovarian | 6.4 (1–28) | 6.7 | 4.5 | 17 | 20 |
Endometrial | 5 (0.1-171) | 2.25 (1–18) | 2 (0.25-17) | Not available | 22 (2.1-84) |
Cervical | 4 (0.1-72) | 4 (1–7) | 3 (0.1-22.6) (+/− chemo) | 7.1 (1–72) (+/− chemo) | SRS + other modality13.7 (5–22.5) |